0.330 (-1.49%)

T-O: 0.0 (08:59:00)
Last updated: 17:00

Fundamental   2.9  
Technical   4.7  
Total Score   7.6  

 Sector Trend+   ST Sell- 


iSaham Fundamental Trend

FCON: 0.51 | Sharpe Ratio: 0.18 | LTS: 5.53

Quarter Reports

Trailing Dividend

Financial Ratios

EPS 20.47 sen
Trailing PE (Sector Median: 75.4) 178.4
PEG 118.09
Altman Z 5.9
Beaver -5.15
Current Ratio 10.45
Debt-Equity (DE) Ratio 0.11
FCF Yield -20.54 %
Dividend Per Share (DPS) 0.0 sen
Revenue QoQ -95.34 %
Revenue YoY -25.48 %
Profit QoQ -73.59 %
Profit YoY 636.53 %
NTA QoQ 7341.58 %
Profit Margin (Sector Median: 6.8) 0.92 %
ROE 164.79 %
ROIC 164.79 %
Dividend Yield (DY) 0.0 %

Fair Value

iSaham Fair Value: 1.49
We have detected and removed a one off gain from the calculation.

Discounted Cash Flow (DCF)5.0% Growth 1.76
Discounted Cash Flow (DCF)-20.6% Growth 1.49
Relative Valuation 0.14
Graham Formula 1.57
Graham Number 0.76
Net Tangible Asset (NTA) 12.42

Advanced Calculators

Calculate the fair value of the stock based on expected growth / risk, contract / award value, forecasted profit or forecasted revenue.

Growth/Risk Fair Value Calculator
Expected growth (%)
Estimated downside / risk (%)
Estimated New DCF Fair Value
Contract/Award Contribution Calculator
Contract/Award Value (in Million)
Estimated Contribution to Stock Price
Estimated New DCF Fair Value
Profit-Based Calculator
Expected Profit (M)
for Year
Estimated New DCF Fair Value
Revenue-Based Calculator
Expected Revenue (M)
for Year
Estimated New DCF Fair Value
Market Pricing
Expected Profit (M) 0.21
Expected Revenue (M) 22.44
Expected Growth (%) -32.0



Market Cap: 33 M.

Number of Shares: 103 M.

Float: Not Available.

Stock highly correlated with


LKL (92%)

KOSSAN (87%)


MGRC provides genome sequencing and analysis services. Our services and pipelines are designed to rapidly sequence and analyse large volumes of genetic data and extract meaningful biological information for downstream research and development. The key components of our commercial operations are our Contract Genomics Services, Sequencing Services, and Data and Access Services. Our services and applications have been used extensively in significant projects, including the mapping of the lung cancer genome, and the sequencing and assembly of the oil palm genome. To date, the company have undertaken projects for large agriculture-based companies, major medical research institutions, and government linked or funded entities in Malaysia and abroad, including United States and Australia. Currently, MGRC are the only player in Malaysia providing commercial bioinformatics analysis services for data from multiple second and third generation sequencing machines, serving public and private sector organizations in Malaysia and internationally. They have established themselves as Malaysia's leading provider of Contract Genomics Services

Sectors: Healthcare, Health Care Equipment & Services, Penny Stocks

Code: 0155


Related Links: Bursa | Annual Report | Announcement

Top Shareholdings

Updated on 4-Oct-2019

Shareholder Value (M)
Synamatix Sdn Bhd 19.26
Koh Kin Lip 1.72
Neuramatix Sdn Bhd 1.38
Mohd Rafael bin Mohd Shamsudin 1.09
Zharif Omar bin Mohamed Radzif 0.96
Munirah binti Haji Abdul Hamid 0.96
Mah Siew Hoe 0.89
Nor Azah binti Adnan 0.8
Inertia AIF Sdn Bhd 0.44
Loh Chai Keong 0.4
Lai Thiam Poh 0.4
Mohamed Roslan bin Mohamed Shamsudin 0.4
Shahril bin Shamsuddin 0.33
Teong Teck Lean 0.33
Encipta Ltd 0.28
Mohamed Radzif bin Mohamed Shamsudin 0.25
Cheah King Fui 0.23
Nor Azizan binti Adnan 0.23
Lim Kian Wat 0.2
Maznah binti Ali 0.17
Noraziah binti Adnan 0.17
S. Elias bin Abd. Rahman Alhabshi 0.17
A Aziz bin Mohd Isa 0.15
Goh Sim Geh 0.15
Kamarudin bin Meranun 0.13
Azlan Shairi bin Asidin 0.12
Rupee Enterprise Sdn. Bhd. 0.11
Che Onn bin Ismail 0.09